Collateral for a security interest recorded Jan 18, 2023 (Oxford Finance LLC).
Term ends Feb 11, 2039 · High confidence
20-year base term ends Feb 11, 2039
Held by Nevakar Injectables Inc.
Filed Jun 23, 2020 as application 16/909,340 · Granted Oct 10, 2023
Base term plus 643 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2019
2039
Clock starts
Feb 11, 2019
Feb 11, 2019
Term ends
Feb 11, 2039
Feb 11, 2039
Granted
Oct 10, 2023
Oct 10, 2023
base term
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
643
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,682,308, US 10,722,454, US 10,722,455.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 643 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 11, 2019, when application 16/272,815, the earliest non-provisional in its chain, was filed (this one was filed Jun 23, 2020) | Feb 11, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +643 days, USPTO patent term adjustment record | Nov 15, 2040 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,682,308, US 10,722,454, US 10,722,455) | capped to Feb 11, 2039 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 11, 2039 | High confidence |
This family
| US 10,682,308 | In force Feb 2039 | Feb 2039 |
| US 10,722,453 | In force Feb 2039 | Feb 2039 |
| US 10,722,454 | In force Feb 2039 | Feb 2039 |
| US 10,722,455 | In force Feb 2039 | Feb 2039 |
| US 11,779,535 | this patent Feb 2039 | Feb 2039 |
| US 12,194,141 | In force Feb 2039 | Feb 2039 |
| Application 18/968,646 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 23, 2020 Reel 53014, frame 923 | Soppimath, Kumaresh; Akasapu, Prem Sagar | Nevakar, LLC | Assignment of Assignor's Interest |
| Jun 23, 2020 Reel 53618, frame 24 | Nevakar, LLC | Nevakar Inc. | Change of Name |
| Aug 13, 2021 Reel 57183, frame 825 | Nevakar Inc. | Nevakar Injectables Inc. | Assignment of Assignor's Interest |
| Jan 18, 2023 Reel 62405, frame 329 | Nevakar Injectables Inc. | Oxford Finance LLC | Security Interest |
| May 4, 2023 Reel 63545, frame 646 | Nevakar Injectables Inc. | H.I.G. Bio - Nevakar, L.P. | Patent Security Agreement |
| May 9, 2023 Reel 63583, frame 948 | Nevakar Injectables Inc. | Novaquest Co.-Investment Fund IX, L.P. | Security Interest |
| May 9, 2023 Reel 63588, frame 122 | Oxford Finance LLC | Novaquest Co.-Investment Fund X, L.P. | Security Interest |
| Sep 3, 2026 Reel 75902, frame 289 | Novaquest Co.-Investment Fund IX, L.P. | Nevakar Injectables Inc. | Release of Security Interest |
| Sep 3, 2026 Reel 75902, frame 359 | H.I.G. Bio - Nevakar, L.P. | Nevakar Injectables Inc. | Release of Security Interest |
| Sep 3, 2026 Reel 76340, frame 73 | Novaquest Co.-Investment Fund X, L.P. | Nevakar Inc.; Nevakar Injectables Inc.; Vyluma Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2039
Term ends Feb 11, 2039. Maintenance fees still fall due before then
Note
The 643 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,682,308, US 10,722,454, US 10,722,455.
Citations
9
later US patents cite this one
That is top 10% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.